,title,source,link,date
0,Cipla Limited (NSE:CIPLA) is favoured by institutional owners who hold 39% of the company,Simply Wall St,news.google.com/articles/CBMikAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1jaXBsYS9jaXBsYS1zaGFyZXMvbmV3cy9jaXBsYS1saW1pdGVkLW5zZWNpcGxhLWlzLWZhdm91cmVkLWJ5LWluc3RpdHV0aW9uYWwtb3duZXJzLXfSAZQBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy9pbi9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uc2UtY2lwbGEvY2lwbGEtc2hhcmVzL25ld3MvY2lwbGEtbGltaXRlZC1uc2VjaXBsYS1pcy1mYXZvdXJlZC1ieS1pbnN0aXR1dGlvbmFsLW93bmVycy13L2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-14
24,Optic Nerves Disorder Treatment Market Rises: North America ...,PR Newswire,news.google.com/articles/CBMigQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL29wdGljLW5lcnZlcy1kaXNvcmRlci10cmVhdG1lbnQtbWFya2V0LXJpc2VzLW5vcnRoLWFtZXJpY2EtdGFrZXMtdGhlLWhlbG0tMzAxOTI2NTg4Lmh0bWzSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-14
38,Otc Drugs Market Forecast Report 2023-2030 | 121 Pages Report,Benzinga,news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9wcmVzc3JlbGVhc2VzLzIzLzA5LzM0NTYwNjY3L290Yy1kcnVncy1tYXJrZXQtZm9yZWNhc3QtcmVwb3J0LTIwMjMtMjAzMC0xMjEtcGFnZXMtcmVwb3J00gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzM0NTYwNjY3?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-14
37,2018 First Generic Drug Approvals - EIN Presswire,EIN News,news.google.com/articles/CBMiS2h0dHBzOi8vd3d3LmVpbm5ld3MuY29tL3ByX25ld3MvNjU1NjExMDA0LzIwMTgtZmlyc3QtZ2VuZXJpYy1kcnVnLWFwcHJvdmFsc9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-14
53,Pre-Exposure Prophylaxis (PrEP) HIV Drugs Market is Anticipated to Increase at a Stable CAGR over the Forecast,openPR,news.google.com/articles/CBMiUmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjA2MzY4L3ByZS1leHBvc3VyZS1wcm9waHlsYXhpcy1wcmVwLWhpdi1kcnVncy1tYXJrZXTSAVFodHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMjA2MzY4L3ByZS1leHBvc3VyZS1wcm9waHlsYXhpcy1wcmVwLWhpdi1kcnVncy1tYXJrZXQ?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-13
39,"Flunarizine Hydrochloride Market Size with stricking 6.7% CAGR from 2023 -2030 add Regional development,",Benzinga,news.google.com/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vcHJlc3NyZWxlYXNlcy8yMy8wOS8zNDUyOTgxMC9mbHVuYXJpemluZS1oeWRyb2NobG9yaWRlLW1hcmtldC1zaXplLXdpdGgtc3RyaWNraW5nLTYtNy1jYWdyLWZyb20tMjAyMy0yMDMwLWFkZC1yZWdpb25hbC1kZXZlbG9wbWXSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzQ1Mjk4MTA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-13
5,Cipla Quality Chemicals Industries Limited (CIPLA.ug) 2023 Annual ...,AfricanFinancials,news.google.com/articles/CBMiO2h0dHBzOi8vYWZyaWNhbmZpbmFuY2lhbHMuY29tL2RvY3VtZW50L3VnLWNpcGxhLTIwMjMtYXItMDAv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-13
6,Cipla's #BerokZindagi Ushers in A New Era of Storytelling with ...,ANI News,news.google.com/articles/CBMinAFodHRwczovL3d3dy5hbmluZXdzLmluL25ld3MvYnVzaW5lc3MvYnVzaW5lc3MvY2lwbGFzLWJlcm9remluZGFnaS11c2hlcnMtaW4tYS1uZXctZXJhLW9mLXN0b3J5dGVsbGluZy13aXRoLWRpZ2l0YWwtY29udGVudC1wbGF0Zm9ybS1maWx0ZXJjb3B5MjAyMzA5MTMxODEwMzfSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-13
35,Unlocking Growth Opportunities in Bronchial Spasm Industry ...,InvestorsObserver,news.google.com/articles/CBMiPWh0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3FtLXByLzgzNzEzNzU1MzgxODY2NzTSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-13
33,"Remdesivir Market Challenges by Players - Bright Gene, Kelun Pharma, Merck, Gilead Sciences Inc., Cipla,",Benzinga,news.google.com/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vcHJlc3NyZWxlYXNlcy8yMy8wOS8zNDU0MDc5OS9yZW1kZXNpdmlyLW1hcmtldC1jaGFsbGVuZ2VzLWJ5LXBsYXllcnMtYnJpZ2h0LWdlbmUta2VsdW4tcGhhcm1hLW1lcmNrLWdpbGVhZC1zY2llbmNlcy1pbmMtY2lwbGEtaGHSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzQ1NDA3OTk?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-09-13
